Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions

Acute Lymphoblastic Leukemia (ALL)Newly Diagnosed Philadelphia Chromosome NegativeAged 60 Years or Older

Interventions

DRUG

Erwinia Chrysanthemi asparaginase

Trial Locations (1)

Memorial Sloan Kettering Cancer Center, New York